Testing effectiveness (Phase 2)Study completedNCT02612610
What this trial is testing
A 12-Week Study in Participants With Refractory Chronic Cough (MK-7264-012)
Who this might be right for
Refractory Chronic Cough
Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 253